Division of Nephrology, Kanazawa Medical University School of Medicine, 1-1 Daigaku, Uchinada, Kahoku, Ishikawa 920-0293, Japan.
Clin Transplant. 2010 Jul;24 Suppl 22:35-8. doi: 10.1111/j.1399-0012.2010.01280.x.
We reported a 40-year-old female case of second renal transplantation with antibody-mediated rejection (AMR) complicated by BK virus nephropathy. She started hemodialysis (HD) at the age of 17 because of IgA nephropathy. At the age of 18, she underwent living-donor kidney transplantation from her father, but two and a half years after transplantation, she developed chronic rejection. This time, she received cadaveric renal transplantation under the negative cross-match (AHG-LCT), and HLA-AB 1 mismatch and -DR 1 mismatch. Immunosuppressive therapy was initiated using the following four immunosuppressants: methylprednisolone, mycophenolate mofetil, cyclosporine, and basiliximab. However, renal graft showed delayed function, the biopsy showed glomerulitis (g2), endarteritis (v1), and cellular infiltration (ptc3) consisting mainly of mononuclear cells in the peritubular capillary with diffusely positive C4d and anti-SV 40 large T-antigen-positive renal tubular epithelial cells on post-operative day 19. The donor-specific antibody for HLA-B46 was proven by the LAB screen method. We performed plasma exchange three times and administered immunoglobulin (15 g in total). Then, methylprednisolone pulse therapy was added, and the serum creatinine (SCr) levels gradually decreased. On post-operative day 44, the patient was removed from HD and was discharged with SCr level of 3.3 mg/dL.
我们报告了一例 40 岁女性病例,该患者第二次肾移植后发生抗体介导的排斥反应(AMR)合并 BK 病毒肾病。她因 IgA 肾病于 17 岁开始接受血液透析(HD)。18 岁时,她接受了来自父亲的活体供肾移植,但移植后两年半,她发生了慢性排斥反应。这次,她在负交叉配型(AHG-LCT)下接受了尸体肾移植,HLA-AB1 错配和-DR1 错配。她接受了以下四种免疫抑制剂的免疫抑制治疗:甲泼尼龙、霉酚酸酯、环孢素和巴利昔单抗。然而,肾移植物功能延迟,活检显示肾小球肾炎(g2)、动脉内膜炎(v1)和细胞浸润(ptc3),主要为单核细胞浸润,术后第 19 天,肾小管周毛细血管弥漫性 C4d 阳性和抗 SV40 大 T 抗原阳性的肾小管上皮细胞。通过 LAB 筛查方法证实供体特异性抗体为 HLA-B46。我们进行了三次血浆置换,并给予免疫球蛋白(总量为 15g)。然后,加用甲泼尼龙脉冲治疗,血清肌酐(SCr)水平逐渐下降。术后第 44 天,患者停止血液透析,出院时 SCr 水平为 3.3mg/dL。